ARCHIVES

Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials.

This article is from The Cancer Letter archive.

Vol. 34 No. 41 | November 7, 2008

Download PDF Visit The Full Archive

Related Articles

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

June 24, 2011

Iressa Just As Effective As Chemotherapy For Second-Line Therapy, Study Finds

November 28, 2008

In Brief: XIIIth Congress Draws Record Number Of Abstracts, 3,000 Registrants So Far; Exhibit Area Sold Out

March 5, 1982

NCAB To Monitor Virus Program; NCI Answers Zinder Report Criticisms

June 28, 1974

Kimes Heads NCI Organ Systems Committee; Changes Being Implemented

April 1, 1988

NCAB Seeks Exemption From New Reimbursement Plan For Clinical Trials, Modification Of Hospice Regs

February 11, 1983